Guideline Implementation Gap in Preeclampsia Prevention: Adherence to Low‐Dose Aspirin Use in Routine Obstetric Practice
Open Access
- 7 November 2026
- journal article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (11)
Abstract
Evidence‐based guidelines recommend the use of low‐dose aspirin (LDA) to prevent preeclampsia. Gaps between recommended and actual care may limit the impact of proven preventive interventions. This study aimed to assess obstetricians’ adherence to LDA prescription for preeclampsia prevention in accordance with the national guideline. This retrospective cohort study included 1150 women who delivered between November 2023 and December 2024. Eligibility for LDA use was determined according to guideline‐defined risk criteria. Adherence was defined as prescribing LDA between 11 and 16 weeks of gestation. The rate of LDA recommendation was assessed and factors associated with LDA prescription were analyzed. 210 women (18.3%) met the criteria for LDA recommendation. However, LDA was prescribed to 97 (46.2%) of these women, indicating that more than half of the candidates missed the opportunity for prophylaxis. Among the 969 women who did not use LDA during pregnancy, 113 (11.7%) actually met the guideline criteria and should have received LDA. In this untreated group, the incidence of preeclampsia was approximately fourfold higher compared with women without an LDA indication (26.5% vs. 8.2%; OR 4.06, 95% CI 2.50–6.58, p < 0.001). Follow‐up at a tertiary healthcare center at or before 16 weeks of gestation was associated with significantly higher rates of appropriate LDA prescription ( p < 0.001). Adherence to national guideline for the prevention of preeclampsia remains suboptimal in Türkiye. This implementation gap represents missed opportunities for the prevention of preeclampsia and underscores the need for targeted educational initiatives and system‐level interventions.Keywords
This publication has 12 references indexed in Scilit:
- Gaps in Low-Dose Aspirin Use for Preeclampsia Prevention: Insights and Clinical ImplicationsInternational Journal of Women's Health, 2025
- Barriers and facilitators of adherence to low-dose aspirin during pregnancy: A co-produced systematic review and COM-B framework synthesis of qualitative evidencePLOS ONE, 2024
- Preeclampsia prevention: a survey study on knowledge and practice among prenatal care providers in EthiopiaAJOG Global Reports, 2023
- Missed opportunity for aspirin prophylaxis for preeclampsia prevention: a cross-sectional study from Sub-Saharan AfricaAJOG Global Reports, 2023
- Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsiaPregnancy Hypertension, 2023
- Gestational Hypertension and PreeclampsiaObstetrics & Gynecology, 2020
- Clinical Influence of Nonadherence With Prophylactic Aspirin in Preventing Preeclampsia in High-Risk PregnanciesHypertension, 2020
- Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromesAmerican Journal of Obstetrics and Gynecology, 2019
- ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During PregnancyObstetrics & Gynecology, 2018
- The ESOMAR Standard Demographic Classification2003